Academic Journal
A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker
| العنوان: | A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker |
|---|---|
| المؤلفون: | Chunmei Wang, John K. Buolamwini |
| المصدر: | Experimental Hematology & Oncology, Vol 8, Iss 1, Pp 1-11 (2019) |
| بيانات النشر: | BMC, 2019. |
| سنة النشر: | 2019 |
| المجموعة: | LCC:Diseases of the blood and blood-forming organs LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| مصطلحات موضوعية: | Concentrative nucleoside transporter 1 (SLC28A1), Splice variant, Intron retention, hCNT1 intron retention, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| الوصف: | Abstract Background The human concentrative nucleoside transporter 1 (hCNT1) a product of the SLC28A1 gene is one of the three concentrative nucleoside transporters, with a substrate specificity for physiological pyrimidine nucleosides. It has recently been implicated in tumor suppression. We have unraveled a splice variant RNA transcript that is overexpressed in some tumor tissues and some cancer cells. This study established that observation. Methods We examined several clones of hCNT1 generated from RT-PCR of total RNA from human kidney tissue purchased from Ambion. The resulting cDNA clones were then sequenced, and a variant that retained intron 4, and skipped some exons fully or partly, specifically exons 5 and 13 were completely missed and only part of exon 6 was spliced. Tissue expression analysis by PCR indicated a similar distribution of expression of RNA of the splice variant hCNT1-IR as that of the dominant variant hCNT1, particularly in the small intestine, kidney and liver. Further, analysis of various tumor samples with PCR primers designed from this novel hCNT1 splice variant (hCNT1-IR) revealed interestingly that it is overexpressed in some cancer tissues relative to normal tissues, particularly kidney, liver and pancreatic cancers. Conclusion We have identified a novel intron retaining and exon skipping splice variant of the hCNT1 nucleoside transporter, and designated it hCNT1-IR, which has a similar tissue expression distribution as the normal hCNT1 variant, but unlike the normal transcript, hCNT1-IR is overexpressed in some cancers and may serve as a potential cancer biomarker. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2162-3619 |
| Relation: | http://link.springer.com/article/10.1186/s40164-019-0144-y; https://doaj.org/toc/2162-3619 |
| DOI: | 10.1186/s40164-019-0144-y |
| URL الوصول: | https://doaj.org/article/44d99b92ddba4ad4a717e14323c42863 |
| رقم الانضمام: | edsdoj.44d99b92ddba4ad4a717e14323c42863 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 21623619 |
|---|---|
| DOI: | 10.1186/s40164-019-0144-y |